Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04698213
Title Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma (TIDE-A)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Consorzio Oncotech

renal cell carcinoma


Avelumab + Axitinib

Age Groups: senior | adult
Covered Countries ITA

No variant requirements are available.